Uncategorized
Startups

BaltTech begins monthly tech survey // Baltimore BioWorks applies for minority business certification // BetaPunch unveils new home page [Startup Roundup]

This is the Startup Roundup. Every Wednesday morning, Technically Baltimore will put together the smaller pieces that make up our startup ecosystem. Gus Sentementes, the BaltTech blogger for the Baltimore Sun, has begun a monthly survey where he asks tech companies in Maryland a different question). For the inaugural survey, he asked tech companies what the “number […]

This is the Startup Roundup. Every Wednesday morning, Technically Baltimore will put together the smaller pieces that make up our startup ecosystem.
Gus Sentementes, the BaltTech blogger for the Baltimore Sun, has begun a monthly survey where he asks tech companies in Maryland a different question). For the inaugural survey, he asked tech companies what the “number one issue they face right now.” Responses came from such companies as Mindgrub Technologies and Bizelo (common themes were capital and recruiting). Sentementes has also been collecting information on tech companies in Maryland using a publicly available Google Spreadsheet.

Baltimore BioWorks, which moved into office space at the University of Maryland BioPark’s BioInnovation Center earlier this month, is now applying for “state certification as a Minority Business Enterprise that would allow the life sciences manufacturing and training firm to bid on state contracts that set aside a slice of business for minority- and women-owned companies,” reports Bmore Media. Next month, BioWorks plans to open a 14,000-square-foot production facility.
BetaPunch, the website that connects other startups with beta testers that Technically Baltimore covered yesterday, unveiled a new home page Tuesday. According to the BetaPunch site, more than 250 startups have used the service to recruit beta testers.
Biotech firm Gliknik Inc., founded in 2007 and located in the city’s Hollins Market neighborhood just nearby the University of Maryland BioPark, has $4.8 million committed of a $15 million planned round, according to SEC filings. Gliknik develops “new therapies for patients with cancer and autoimmune/inflammatory diseases,” according to its website.

Companies: Baltimore BioWorks / BetaPunch
Engagement

Join the conversation!

Find news, events, jobs and people who share your interests on Technical.ly's open community Slack

Trending

Baltimore daily roundup: Medtech made in Baltimore; Sen. Sanders visits Morgan State; Humane Ai review debate

Baltimore daily roundup: The city's new esports lab; a conference in Wilmington; GBC reports $4B of economic activity

Baltimore daily roundup: Find your next coworking space; sea turtle legislation; Dali raided and sued

Baltimore coworking guide: 21 spaces where you don’t have to work alone

Technically Media